Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators.
BACKGROUND AND PURPOSE: Stroke risk increases with age in patients who have nonvalvular atrial fibrillation. It is uncertain whether the efficacy of stroke prevention therapies in atrial fibrillation changes as patients age. The objective of this study was to determine the effect of age on the relat...
主要な著者: | van Walraven, C, Hart, R, Connolly, S, Austin, P, Mant, J, Hobbs, F, Koudstaal, P, Petersen, P, Perez-Gomez, F, Knottnerus, J, Boode, B, Ezekowitz, MD, Singer, D |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2009
|
類似資料
-
Stroke prevention in atrial fibrillation
著者:: Hobbs, F
出版事項: (2003) -
Challenges of stroke prevention in patients with atrial fibrillation in clinical practice.
著者:: Hobbs, F, 等
出版事項: (2011) -
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.
著者:: Mant, J, 等
出版事項: (2007) -
Left Atrial Appendage Exclusion for Stroke Prevention in Atrial Fibrillation
著者:: Taral K. Patel, 等
出版事項: (2012-01-01) -
Should we screen for atrial fibrillation?
著者:: Lown, M, 等
出版事項: (2017)